Clinical Trials Logo

Clinical Trial Summary

This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.


Clinical Trial Description

This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered followed by G-CSF. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00208936
Study type Interventional
Source Emory University
Contact
Status Terminated
Phase Phase 2
Start date January 1996

See also
  Status Clinical Trial Phase
Recruiting NCT05054933 - Ultrasound Capsule Endoscopy for Esophagus Examination N/A
Completed NCT04090554 - Cytospongeâ„¢ Feasibility Study in Tanzania N/A
Active, not recruiting NCT03962179 - Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent) N/A
Completed NCT03549494 - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction Phase 2
Recruiting NCT04481100 - CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer Phase 2
Completed NCT03859557 - The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
Completed NCT00977678 - Drop in Gastroscopy - Experience After 9 Months N/A
Recruiting NCT04068480 - Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy
Completed NCT00874263 - Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies N/A
Terminated NCT00442507 - Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction Phase 2
Recruiting NCT03832959 - Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study. N/A
Withdrawn NCT02569073 - Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain Phase 4
Recruiting NCT05252078 - Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients Phase 2
Recruiting NCT00260585 - Esophageal Cancer Risk Registry
Completed NCT03187314 - Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer Phase 2
Recruiting NCT05004155 - Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population
Recruiting NCT05469152 - Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases N/A
Recruiting NCT05877300 - Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement Phase 1
Recruiting NCT03267355 - Indications and Outcomes of Endoscopic Ultrasound in Tanta N/A
Recruiting NCT05311787 - The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery N/A